Term
|
Definition
| drug effects that are not hte desired therapeutic effects; may be unpleasant or even dangerous |
|
|
Term
|
Definition
| name given to a drug by the pharmaceutical company developed it; also called a trade name |
|
|
Term
|
Definition
| name that reflects the chemical structure of a drug |
|
|
Term
|
Definition
| chemicals that are introduced into the body to bring about some sort of change |
|
|
Term
| Food and Drug Administration |
|
Definition
| federal agency responsible for the regulation and enforcement of drug evaluation and distribution policies |
|
|
Term
|
Definition
| drugs sold by their chemical name; not brand name products |
|
|
Term
|
Definition
| the original designation that a drug is given when the drug company that developed it applies for the approval process |
|
|
Term
|
Definition
| process of altering DNA, usually of bacteria, to produce a chemical to be used as adrug |
|
|
Term
|
Definition
| drugs that have been discovered but would not be profitable for a drug company to develop; usually drugs would treat only a small number of people; these orphans can be adopted by drug companies to develop |
|
|
Term
| over-the-counter (OTC) drugs |
|
Definition
| drugs that are available without a prescription for self-treatment of a variety of complaints; deemed to be safe when used as directed |
|
|
Term
|
Definition
| the study of the biological effects of chemicals |
|
|
Term
|
Definition
| clincial pharmacology- the branch of pharmacology that deals with drugs; chemicals that are used in medicine for the treatment, prevention, and diagnosis of disease in humans |
|
|
Term
|
Definition
| a pilot study of a potential drug done with a small number of selected, healthy human volunteers |
|
|
Term
|
Definition
| a clinical study of a proposed drug by selected physicians using actual patients who have the disorder the drug is designed to treat; patients must provide informed consent |
|
|
Term
|
Definition
| use of proposed drug on a wide scale in the clinical setting with patients who have the disease the drug is thought to treat |
|
|
Term
|
Definition
| continual evaluation of a drug after it has been released for marketing |
|
|
Term
|
Definition
| inital trial of a chemical thought to have therapeutic potential; uses laboratory animals, not human subjects |
|
|
Term
|
Definition
| having adverse effects on the fetus |
|
|
